Puriblood Medical Co., Ltd. (TPEX:6847)
Taiwan · Delayed Price · Currency is TWD 74.10
+0.60 (0.82%)
Feb 11, 2026, 2:56 PM CST
Puriblood Medical Revenue
Puriblood Medical had revenue of 40.25M TWD in the half year ending June 30, 2025, with 24.67% growth. This brings the company's revenue in the last twelve months to 117.35M, down -7.28% year-over-year. In the year 2024, Puriblood Medical had annual revenue of 110.67M, down -11.65%.
Revenue (ttm)
117.35M
Revenue Growth
-7.28%
P/S Ratio
8.99
Revenue / Employee
2.67M
Employees
44
Market Cap
1.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 110.67M | -14.60M | -11.65% |
| Dec 31, 2023 | 125.27M | -12.17M | -8.86% |
| Dec 31, 2022 | 137.44M | 82.86M | 151.79% |
| Dec 31, 2021 | 54.59M | 15.94M | 41.25% |
| Dec 31, 2020 | 38.65M | 35.55M | 1,149.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Ma Kuang Healthcare Holding | 1.10B |
| Anxo Pharmaceutical | 883.22M |
| Prince Pharmaceutical | 798.27M |
| Level Biotechnology | 753.30M |
| Kim Forest Enterprise | 531.58M |
| Caliway Biopharmaceuticals | 34.99M |